Search

Author/Creator Cuevas, Beatriz

1. Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program. Issue 5 (30th March 2015)

Authors:
García‐Gutiérrez, Valentín; Martinez‐Trillos, Alejandra; Lopez Lorenzo, Jose Luis; Bautista, Guiomar; Martin Mateos, Maria Luisa; Alvarez‐Larrán, Alberto; Iglesias Pérez, Ana; Romo Collado, Andrés; Fernandez, Angeles; Portero, Angeles; Cuevas, Beatriz; Ruiz, Concepción; Romero, Esperanza; Ortega,...
Journal:
American journal of hematology
Issue:
Volume 90:Issue 5(2015:May)
Page Start:
429
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia. (17th April 2017)

Authors:
Hernández Boluda, Juan‐Carlos; Correa, Juan‐Gonzalo; Alvarez‐Larrán, Alberto; Ferrer‐Marín, Francisca; Raya, José‐María; Martínez‐López, Joaquín; Velez, Patricia; Pérez‐Encinas, Manuel; Estrada, Natalia; García‐Gutiérrez, Valentín; Fox, María‐Laura; Luño, Elisa; Kerguelen, Ana; Cuevas, Beatriz; D...
Journal:
British journal of haematology
Issue:
Volume 181:Number 3(2018)
Page Start:
397
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Cytoreductive treatment in patients with CALR‐mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential Thrombocythaemia. (3rd August 2020)

Authors:
Alvarez‐Larrán, Alberto; Angona, Anna; Andrade‐Campos, Marcio; Soledad Noya, M.; Teresa Gómez‐Casares, M.; Cuevas, Beatriz; Caballero, Gonzalo; García‐Hernández, Carmen; García‐Gutiérrez, Valentín; Palomino, Alicia; Ferrer‐Marín, Francisca; Isabel Mata‐Vázquez, M.; Moretó, Ana; Magro, Elena; Muri...
Journal:
British journal of haematology
Issue:
Volume 192:Number 6(2021)
Page Start:
988
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID‐19. Issue 12 (27th September 2022)

Authors:
Barbui, Tiziano; Carobbio, Alessandra; Ghirardi, Arianna; Iurlo, Alessandra; Sobas, Marta Anna; Elli, Elena Maria; Rumi, Elisa; De Stefano, Valerio; Lunghi, Francesca; Marchetti, Monia; Daffini, Rosa; Gasior Kabat, Mercedes; Cuevas, Beatriz; Fox, Maria Laura; Andrade‐Campos, Marcio Miguel; Paland...
Journal:
American journal of hematology
Issue:
Volume 97:Issue 12(2022)
Page Start:
E470
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera. (21st December 2015)

Authors:
Alvarez‐Larrán, Alberto; Kerguelen, Ana; Hernández‐Boluda, Juan C.; Pérez‐Encinas, Manuel; Ferrer‐Marín, Francisca; Bárez, Abelardo; Martínez‐López, Joaquín; Cuevas, Beatriz; Mata, M. Isabel; García‐Gutiérrez, Valentín; Aragües, Pilar; Montesdeoca, Sara; Burgaleta, Carmen; Caballero, Gonzalo; Her...
Journal:
British journal of haematology
Issue:
Volume 172:Number 5(2016)
Page Start:
786
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis. Issue 1 (20th January 2023)

Authors:
Mosquera-Orgueira, Adrián; Pérez-Encinas, Manuel; Hernández-Sánchez, Alberto; González-Martínez, Teresa; Arellano-Rodrigo, Eduardo; Martínez-Elicegui, Javier; Villaverde-Ramiro, Ángela; Raya, José-María; Ayala, Rosa; Ferrer-Marín, Francisca; Fox, María-Laura; Velez, Patricia; Mora, Elvira; Xicoy,...
Journal:
HemaSphere
Issue:
Volume 7:Issue 1(2023)
Page Start:
e818
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Real‐world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea. Issue 13 (13th April 2022)

Authors:
Alvarez‐Larrán, Alberto; Garrote, Marta; Ferrer‐Marín, Francisca; Pérez‐Encinas, Manuel; Mata‐Vazquez, M. Isabel; Bellosillo, Beatriz; Arellano‐Rodrigo, Eduardo; Gómez, Montse; García, Regina; García‐Gutiérrez, Valentín; Gasior, Mercedes; Cuevas, Beatriz; Angona, Anna; Gómez‐Casares, María Teresa...
Journal:
Cancer
Issue:
Volume 128:Issue 13(2022)
Page Start:
2441
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗